As of 2026-04-02, the Fair Value of Aligos Therapeutics Inc (ALGS) is -37.17 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.43 USD, the upside of Aligos Therapeutics Inc is -600.24%.
With the market price of 7.43 USD and our fair value calculation, Aligos Therapeutics Inc (ALGS) is not a good investment. Investing in Aligos stocks now will result in a potential loss of 600.24%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -128.33 | -96.05 | -87.68 | -131.21 | -24.19 | -93.49 |
| YoY growth | -18.23% | 25.15% | 8.72% | -49.65% | 81.56% | 9.51% |
| Market Cap (mil) | 45.99 |
| P/E | |
| Forward P/E |
| EPS | -3.91 |
| Avg earnings growth rate | 9.51% |
| TTM earnings | -24.19 |